Intellia Therapeutics, Inc. (NTLA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 974.3M |
| Enterprise Value | 912.17M |
| P/E Ratio | -3.82 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 30.15 |
| Price/Book Ratio | 2.36 |
| Enterprise/Revenue | 29.6 |
| Enterprise/EBITDA | -4.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -6.72 |
| Operating Margin | -7.12 |
| Return On Assets | -0.47 |
| Return On Equity | -0.58 |
| Revenue | 67.67M |
| Revenue/Share | 0.45 |
| Gross Profit | 51.75M |
| EBITDA | -396.77M |
| Net Income | -412.69M |
| Diluted EPS | -3.81 |
| Total Cash | 437.76M |
| Total Cash/Share | 3.28 |
| Total Debt | 73.41M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 6.65 |
| Book Value Per Share | 5.45 |
| 52-Week Change | 22.05 |
| 52-Week High | 28.25 |
| 52-Week Low | 7.95 |
| Moving Average 50 Days | 13.29 |
| Moving Average 200 Days | 12.42 |
| Average Volume | 4.97M |
| Shares Outstanding | 139.72M |
| % Held by Institutions | 122.4 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |